Scientists develop test providing new pathway for identifying obesity, diabetes drugs

Sep 16, 2010

Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes.

The new test, which the scientists call a simple assay, will allow researchers to look through hundreds of thousands of compounds for those that have potential to block the action of an known as ghrelin O-acyltransferase (GOAT). If drugs can be found that safely suppress the action of GOAT, they may help people who have clinical problems with appetite, obesity, and diabetes.

"There hasn't been a simple screen until now," says Kim D. Janda, Ph.D., a professor in the Departments of Chemistry and Immunology and Microbial Science, member of The Skaggs Institute for Chemical Biology, and director of The Worm Institute for Research and Medicine at Scripps Research.

Janda and Amanda Garner, Ph.D., a research associate in his laboratory, describe the new approach—which may also¬ prove useful for investigating other enzymes involved in a variety of diseases—in an advance, online Early edition of the journal on September 15, 2010.

A Tempting Target

Even though GOAT was only discovered recently, in 2008, scientists had speculated for years that it had to exist. After all, its target (ghrelin, or the "G" in the acronym GOAT) had been known for more than a decade.

Ghrelin, a small peptide hormone that is mainly produced in the stomach, signals hunger, typically before meals. Ghrelin has been associated with Prader-Willi syndrome a common genetic cause of in which patients have exceptionally high ghrelin levels.

The biology of ghrelin is quite intricate. For ghrelin to impact the body's , it must move from the stomach to the brain, where it acts on neurons. GOAT acts as a "passport" check point station for the processing of 'pro-ghrelin.'

"Without GOAT's modification of 'pro-ghrelin,' ghrelin's entry into the brain, and thus its medicinal implications, are nullified," said Janda. "That's why GOAT has been coveted as a promising therapeutic target for obesity and diabetes."

However, the task of finding drug-like compounds that target GOAT has been complicated by the fact that the enzyme is difficult to work with. As a membrane-bound protein, GOAT cannot easily be purified to homogeneity and has to be suspended in a fatty environment.

Most critically, however, no user-friendly high-throughput screening tests had been developed for this class of enzymes. Current assay technology for targets similar to GOAT rely on radiolabeling techniques, which are labor-intensive and require additional safety precautions.

When Janda and Garner set out to develop an assay to monitor GOAT's activity, they aimed to change this situation.

Taking a Fresh Approach

The scientists were particularly interested in designing a fluorescence-based assay for GOAT. In contrast to radiolabeling techniques, fluorescence assays are safe, can easily be performed in a high-throughput format, and require only a simple light source.

In developing their new approach, the team was inspired by enzyme immunoassay strategies commonly used in biology, chemistry, and medicine, and by "click chemistry," a concept developed at Scripps Research. Because the amount of ghrelin modified by GOAT is minute, the scientists also used the principle of multi-turnover signal amplification for accurate detection.

In the end, the team succeeded in designing and creating the new technology—which they call "catalytic assay using enzyme-linked click chemistry assay" (cat-ELCCA).

"This new assay technology is both highly sensitive and reproducible," noted Janda, "making it an excellent assay for high-throughput screening."

Janda and Garner are now further developing the assay so that researchers can screen thousands to millions of compounds at once against the activity of GOAT.

Explore further: The origins of handedness in life

More information: Angewandte Chemie article, "cat-ELCCA: A Robust Method to Monitor the Fatty Acid Acyltransferase Activity of Ghrelin O-Acyltransferase (GOAT)," onlinelibrary.wiley.com/doi/10… e.201003387/abstract

Related Stories

Fatty foods fire up hunger hormone

Jun 06, 2009

New research led by the University of Cincinnati (UC) suggests that the hunger hormone ghrelin is activated by fats from the foods we eat—not those made in the body—in order to optimize nutrient metabolism and promote ...

The phony goat gets the worm

Mar 28, 2006

IBM researchers have designed a new way to detect and thwart attacks on computer networks. Code named "Billy Goat," the intrusion detection tool provides both early detection of worm attacks and fewer false alarms than other ...

Scientists develop a new strategy to fight obesity

Oct 27, 2008

The antibody works against the gastric hormone ghrelin (pronounced "grell-in"), which has been linked to weight gain and fat storage through its metabolic actions. These findings point towards a potentially novel treatment ...

Hormone ghrelin can boost resistance to Parkinson's disease

Nov 25, 2009

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of ...

Gut hormone makes food look even yummier

May 06, 2008

A gut hormone that causes people to eat more does so by making food appear more desirable, suggests a new report in the May issue of Cell Metabolism, a publication of Cell Press. In a brain imaging study of individuals, the re ...

Recommended for you

The origins of handedness in life

16 hours ago

Handedness is a complicated business. To simply say life is left-handed doesn't even begin to capture the blooming hierarchy of binary refinements it continues to evolve. Over the years there have been numerous ...

Driving cancer cells to suicide

Sep 30, 2014

Ludwig Maximilian University of Munich researchers report that a new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs. They have also pinpointed the relevant target ...

User comments : 0